A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic Non-Erosive Gastroesophageal Reflux Disease (NERD)
Study sponsor: Phathom Pharmaceuticals, Inc. · PHAT
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-11-21Actual
Enrollment · participants776Actual
Source updated2023-12-29Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.